315 related articles for article (PubMed ID: 9462724)
1. Anti-EGFR monoclonal antibodies which act as EGF, TGF alpha, HB-EGF and BTC antagonists block the binding of epiregulin to EGFR-expressing tumours.
Modjtahedi H; Komurasaki T; Toyoda H; Dean C
Int J Cancer; 1998 Jan; 75(2):310-6. PubMed ID: 9462724
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies directed against the EGF receptor show differential bindings of amphiregulin and EGF to the EGF receptor.
Modjtahedi H; Cohen B; Dean C
Int J Oncol; 1997 Feb; 10(2):339-47. PubMed ID: 21533382
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies to the EGF receptor act as betacellulin antagonists.
Modjtahedi H; Dean C
Biochem Biophys Res Commun; 1996 Apr; 221(3):625-30. PubMed ID: 8630011
[TBL] [Abstract][Full Text] [Related]
4. The binding of HB-EGF to tumour cells is blocked by mAbs which act as EGF and TGF alpha antagonists.
Modjtahedi H; Dean C
Biochem Biophys Res Commun; 1995 Feb; 207(1):389-97. PubMed ID: 7857293
[TBL] [Abstract][Full Text] [Related]
5. The human EGF receptor as a target for cancer therapy: six new rat mAbs against the receptor on the breast carcinoma MDA-MB 468.
Modjtahedi H; Styles JM; Dean CJ
Br J Cancer; 1993 Feb; 67(2):247-53. PubMed ID: 8094290
[TBL] [Abstract][Full Text] [Related]
6. Involvement of epidermal growth factor receptor in chemically induced mouse bladder tumour progression.
el-Marjou A; Delouvée A; Thiery JP; Radvanyi F
Carcinogenesis; 2000 Dec; 21(12):2211-8. PubMed ID: 11133810
[TBL] [Abstract][Full Text] [Related]
7. Epiregulin, a novel member of the epidermal growth factor family, is an autocrine growth factor in normal human keratinocytes.
Shirakata Y; Komurasaki T; Toyoda H; Hanakawa Y; Yamasaki K; Tokumaru S; Sayama K; Hashimoto K
J Biol Chem; 2000 Feb; 275(8):5748-53. PubMed ID: 10681561
[TBL] [Abstract][Full Text] [Related]
8. The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4.
Riese DJ; Kim ED; Elenius K; Buckley S; Klagsbrun M; Plowman GD; Stern DF
J Biol Chem; 1996 Aug; 271(33):20047-52. PubMed ID: 8702723
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of EGFR ligands on endocytic sorting of the receptor.
Roepstorff K; Grandal MV; Henriksen L; Knudsen SL; Lerdrup M; Grøvdal L; Willumsen BM; van Deurs B
Traffic; 2009 Aug; 10(8):1115-27. PubMed ID: 19531065
[TBL] [Abstract][Full Text] [Related]
10. ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis.
Révillion F; Lhotellier V; Hornez L; Bonneterre J; Peyrat JP
Ann Oncol; 2008 Jan; 19(1):73-80. PubMed ID: 17962208
[TBL] [Abstract][Full Text] [Related]
11. Activation of ErbB4 by the bifunctional epidermal growth factor family hormone epiregulin is regulated by ErbB2.
Riese DJ; Komurasaki T; Plowman GD; Stern DF
J Biol Chem; 1998 May; 273(18):11288-94. PubMed ID: 9556621
[TBL] [Abstract][Full Text] [Related]
12. Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency.
Hinkle CL; Sunnarborg SW; Loiselle D; Parker CE; Stevenson M; Russell WE; Lee DC
J Biol Chem; 2004 Jun; 279(23):24179-88. PubMed ID: 15066986
[TBL] [Abstract][Full Text] [Related]
13. Internalization mechanisms of the epidermal growth factor receptor after activation with different ligands.
Henriksen L; Grandal MV; Knudsen SL; van Deurs B; Grøvdal LM
PLoS One; 2013; 8(3):e58148. PubMed ID: 23472148
[TBL] [Abstract][Full Text] [Related]
14. Effects of different ligands on epidermal growth factor receptor (EGFR) nuclear translocation.
Faria JAQA; de Andrade C; Goes AM; Rodrigues MA; Gomes DA
Biochem Biophys Res Commun; 2016 Sep; 478(1):39-45. PubMed ID: 27462018
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer.
Tanaka Y; Miyamoto S; Suzuki SO; Oki E; Yagi H; Sonoda K; Yamazaki A; Mizushima H; Maehara Y; Mekada E; Nakano H
Clin Cancer Res; 2005 Jul; 11(13):4783-92. PubMed ID: 16000575
[TBL] [Abstract][Full Text] [Related]
16. EGFR blockade by tyrosine kinase inhibitor or monoclonal antibody inhibits growth, directs terminal differentiation and induces apoptosis in the human squamous cell carcinoma HN5.
Modjtahedi H; Affleck K; Stubberfield C; Dean C
Int J Oncol; 1998 Aug; 13(2):335-42. PubMed ID: 9664130
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human betacellulin. Molecular structure, biological activities, and receptor interaction.
Watanabe T; Shintani A; Nakata M; Shing Y; Folkman J; Igarashi K; Sasada R
J Biol Chem; 1994 Apr; 269(13):9966-73. PubMed ID: 8144591
[TBL] [Abstract][Full Text] [Related]
18. Auto- and cross-induction within the mammalian epidermal growth factor-related peptide family.
Barnard JA; Graves-Deal R; Pittelkow MR; DuBois R; Cook P; Ramsey GW; Bishop PR; Damstrup L; Coffey RJ
J Biol Chem; 1994 Sep; 269(36):22817-22. PubMed ID: 8077234
[TBL] [Abstract][Full Text] [Related]
19. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands.
Sahin U; Weskamp G; Kelly K; Zhou HM; Higashiyama S; Peschon J; Hartmann D; Saftig P; Blobel CP
J Cell Biol; 2004 Mar; 164(5):769-79. PubMed ID: 14993236
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block growth factor-receptor interaction.
Modjtahedi H; Eccles S; Box G; Styles J; Dean C
Br J Cancer; 1993 Feb; 67(2):254-61. PubMed ID: 7679281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]